Please assess the completion status of the following clinical trial:

Trial Title: Clarithromycin is an Adjunct to Scaling and Root Planing

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients age ranged between 30- 50 years with chronic periodontitis~* Patients with Probing Depth (PD)- \>5mm, Clinical Attachment Level( CAL)- \>3mm~* Systemically healthy individuals~Exclusion Criteria:~* Patients below the age of 30 years~* Patients who have undergone periodontal therapy 3 months prior to study~* Active /passive smokers~* Any antibiotic use 3 months prior to study~* Pregnant women and lactating mothers~* Un co- operative/ retarded patients~* Drug allergy/ other allergies~* Any systemic diseases

- Gender: ALL
- Minimum Age: 30 Years
- Maximum Age: 50 Years
- Healthy Volunteers: t

Study Arms:
- test group (Type: EXPERIMENTAL): Base line scaling and root planing was done. Clarithromycin tablet 500 mg( Clarino-500) was given for a period of 7 days orally two times per day
- control (Type: NO_INTERVENTION): scaling and root planing

Based on this trial design, predict the completion outcome and termination type (if applicable).